Bayer has entered into an exclusive licensing agreement with Dewpoint Therapeutics, Inc. for a heart disease programme to treat dilated cardiomyopathy (DCM) patients, who are characterized through ...
Merck’s Keytruda receives European approval for two new indications in gynaecologic cancers: Rahway, New Jersey Friday, October 25, 2024, 09:00 Hrs [IST] Merck, known as MSD out ...